In 115 patients with proliferative diabetic retinopathy and macular oedema found by intraoperative OCT during vitrectomy, anti-VEGF given during surgery (ranibizumab or conbercept) improved vision and macular thickness vs delayed ranibizumab; 109 completed 6 months.
RCTn = 115
Zhu et al. COMPARE COMBINED USE OF ANTI-VEGF DRUGS DURING OR AFTER PARS PLANA VITRECTOMY FOR DIABETIC MACULAR EDEMA GUIDED BY MICROSCOPE-INTEGRATED OPTICAL COHERENCE TOMOGRAPHY